Methods to bypass CD+4 cells in the induction of an immune response

Details for Australian Patent Application No. 2005321905 (hide)

Owner MannKind Corporation

Inventors Bot, Adrian Ion; Diamond, David C.

Agent Davies Collison Cave

Pub. Number AU-A-2005321905

PCT Pub. Number WO2006/071990

Priority 60/640,821 29.12.04 US

Filing date 29 December 2005

Wipo publication date 6 July 2006

International Classifications

A61K 39/12 (2006.01) Medicinal preparations containing antigens or antibodies - Viral antigens

A61K 39/29 (2006.01) Medicinal preparations containing antigens or antibodies - Hepatitis virus

A61K 39/39 (2006.01) Medicinal preparations containing antigens or antibodies - characterised by the immunostimulating additives, e.g. chemical adjuvants

A61P 35/00 (2006.01) Antineoplastic agents

Event Publications

2 August 2007 PCT application entered the National Phase

  PCT publication WO2006/071990 Priority application(s): WO2006/071990

26 July 2012 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired

  This application lapsed under section 142(2)(d). Examination has been requested or an examination report has issued for this application. Note that applications or patents shown as lapsed or ceased may be restored at a later date.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2005321912-Treatment for cutaneous metastases

2005321904-Methods to elicit, enhance and sustain immune responses against MHC class I-restricted epitopes, for prophylactic or therapeutic purposes